Cambridge Heart (NSDQ:CAMH) remained in the red in its 3rd quarter after the company restructured its operations in July, but narrowed its losses by 16.6%.
Wall Street Beat
Mako Surgical prices $40M offering | Wall Street Beat
Mako Surgical (NSDQ:MAKO) priced a stock offering of more than 3 million shares at $13.15 apiece, raising some $40 million in total.
Mako Surgical preps $40M public offering | Wall Street Beat
Mako Surgical (NSDQ:MAKO) said it’s planning to sell some 3 million shares of its own stock in an offering worth about $40 million.*
Nihon Kohden grabs Defibtech | Wall Street Beat
Hologic guides low for 2013, expecting $25M impact of the device tax
HeartWare revenue grows, losses widen in Q3
HeartWare International (NSDQ:HTWR) saw strong growth in its sales in the 3rd quarter, but increased its losses by 79% compared with the same period last year.
KCI carves out TSS bedmaking biz to Getinge for $275M | Wall Street Beat
Kinetic Concepts said it’s closed the sale of its Therapeutic Support Systems business to Swedish medical device company Getinge (PINK:GETI B) for $275 million.
Given imaging surges in Q3 net income; shares down
Given Imaging saw moderate growth in revenue during its 3rd quarter, and posted a 60% increase in net income.
The Israel-based medical device maker posted $6 million in profit, or 19¢ per share on sales of $45.4 million for the 3 months ended Sept. 30. That compared with a net income of $3.8 million, or 12¢ per share on sales of $44.7 million during the same period last year.
Accuray’s sales sink and losses narrow in Q1
NxStage posts record-breaking Q3 results, shares gain 13%
NxStage Medical (NSDQ:NXTM) posted yet another record-breaking quarter, cutting losses in half and reporting strong growth in sales.
Becton Dickinson expects medtech tax to cut 3% from next year’s bottom line
Becton Dickinson & Co. (NYSE:BDX) is expecting the medical device tax to cut about 3% off of its 2013 earnings growth, chairman, president & CEO Vincent Forlenza said during an earnings call this week.